Ivermectin as a potential treatment for mild to moderate COVID-19 – A double blind randomized placebo-controlled trial
Ravikirti, Ranjini Roy, Chandrima Pattadar, Rishav Raj, Neeraj Agarwal, Bijit Biswas, Pramod Kumar Majhi, Deependra Kumar Rai, Shyama, Anjani Kumar, Asim Sarfaraz
doi: https://doi.org/10.1101/2021.01.05.21249310
Ravikirti
1Department of General Medicine, All India Institute of Medical Sciences (AIIMS), Patna, India
Roles: Additional Professor and Head
Ranjini Roy
2Department of General Medicine, AIIMS, Patna, India
Roles: Postgraduate Trainee
Chandrima Pattadar
2Department of General Medicine, AIIMS, Patna, India
Roles: Postgraduate Trainee
Rishav Raj
3Department of General Medicine, AIIMS, Patna
Roles: Postgraduate Trainee
Neeraj Agarwal
4Department of Community and Family Medicine, AIIMS, Bibi Nagar, India
Roles: Professor and Head
Bijit Biswas
5Department of Community and Family Medicine, AIIMS, Patna, India
Roles: Senior Resident
Pramod Kumar Majhi
6Department of Pharmacology, AIIMS, Patna, India
Roles: Assistant Professor and Head
Deependra Kumar Rai
7Department of Pulmonary Medicine, AIIMS, Patna, India
Roles: Additional Professor and Head
Shyama
3Department of General Medicine, AIIMS, Patna
Roles: Assistant Professor
Anjani Kumar
3Department of General Medicine, AIIMS, Patna
Roles: Assistant Professor
Asim Sarfaraz
9Department of Microbiology, AIIMS, Patna
Roles: Assistant Professor

Data Availability
The data can be made available by the corresponding author on rasonable request.
Posted January 09, 2021.
Ivermectin as a potential treatment for mild to moderate COVID-19 – A double blind randomized placebo-controlled trial
Ravikirti, Ranjini Roy, Chandrima Pattadar, Rishav Raj, Neeraj Agarwal, Bijit Biswas, Pramod Kumar Majhi, Deependra Kumar Rai, Shyama, Anjani Kumar, Asim Sarfaraz
medRxiv 2021.01.05.21249310; doi: https://doi.org/10.1101/2021.01.05.21249310
Ivermectin as a potential treatment for mild to moderate COVID-19 – A double blind randomized placebo-controlled trial
Ravikirti, Ranjini Roy, Chandrima Pattadar, Rishav Raj, Neeraj Agarwal, Bijit Biswas, Pramod Kumar Majhi, Deependra Kumar Rai, Shyama, Anjani Kumar, Asim Sarfaraz
medRxiv 2021.01.05.21249310; doi: https://doi.org/10.1101/2021.01.05.21249310
Subject Area
Subject Areas
- Addiction Medicine (163)
- Allergy and Immunology (416)
- Anesthesia (92)
- Cardiovascular Medicine (865)
- Dermatology (98)
- Emergency Medicine (251)
- Epidemiology (8587)
- Gastroenterology (390)
- Genetic and Genomic Medicine (1766)
- Geriatric Medicine (168)
- Health Economics (373)
- Health Informatics (1250)
- Health Policy (624)
- Hematology (197)
- HIV/AIDS (379)
- Medical Education (192)
- Medical Ethics (51)
- Nephrology (214)
- Neurology (1691)
- Nursing (97)
- Nutrition (252)
- Oncology (930)
- Ophthalmology (264)
- Orthopedics (102)
- Otolaryngology (172)
- Pain Medicine (114)
- Palliative Medicine (40)
- Pathology (254)
- Pediatrics (538)
- Primary Care Research (209)
- Public and Global Health (3863)
- Radiology and Imaging (626)
- Respiratory Medicine (522)
- Rheumatology (208)
- Sports Medicine (158)
- Surgery (191)
- Toxicology (36)
- Transplantation (101)
- Urology (76)